|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.1000 - 2.1900|
|52 Week Range||1.8800 - 7.5720|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.99|
MedMen Enterprises Inc. (“MedMen” or the “Company”) (MMEN.CN) (MMNFF) today announced its expansion into Florida with the opening of a retail location in West Palm Beach at 539 Clematis Street. MedMen expects retail locations in Key West and Orlando to follow. Florida is the third most populous state with a robust medical cannabis program serving over 200,000 qualified patients. Of the 15 new locations MedMen plans to open across the U.S. in 2019, 12 will be in Florida, where the Company is licensed for up to 35 retail locations.
(“MedMen” or the “Company”) (MMEN.CN) (MMNFF) (FSE:A2JM6N) is pleased to partner with Equality California, the largest statewide LGBTQ civil rights organization. During the month of June at all California stores, MedMen will donate 15% of proceeds from limited-edition Pride products to advance LGBTQ equality.
MedMen Enterprises Inc (OTC: MMNFF ), a cannabis retailer with operations across the United States, announced Thursday evening an agreement to buy MattnJeremy Inc, LLC, also known as One Love Beach Club ...
MedMen Enterprises Inc. (“MedMen” or the “Company”) (MMEN.CN) (MMNFF) (FSE:A2JM6N) today announced that the City of Pasadena has awarded the Company one of six commercial retail and delivery licenses (subject to obtaining properly zoned real estate and a Conditional Use Permit), further enhancing its industry-leading footprint. “As we continue to grow our footprint in the U.S., California remains our home base and the most strategic market in our industry today,” said Adam Bierman, MedMen co-founder and chief executive officer. “The City ran a very competitive process and we are honored to be among those chosen to operate in Pasadena.
(“MedMen” or the “Company”) (MMEN.CN) (MMNFF) announced that it has signed a definitive agreement to acquire a 100% stake in MattnJeremy, Inc. LLC d/b/a One Love Beach Club (“One Love”). The acquisition further enhances MedMen’s industry-leading California footprint, adding a premier location strategically located between its Santa Ana and LAX locations. “We’re excited to welcome Long Beach to the MedMen family and continue our growth in the most important cannabis market in the world,” said Adam Bierman, MedMen CEO.
A lawsuit filed against MedMen Enterprises Inc. (OTC: MMNFF ) that argued CEO Adam Bierman and President Andrew Modlin made decisions in their own personal interest rather than that of shareholders has ...
By Brendan Bures New Yorkers love to joke about its little brother New Jersey, ribbing any and all of that state’s shortcomings, but the pair are two peas on a pod when it comes to marijuana reform. Just ...
(“MedMen” or the “Company”) (MMEN.CN) (MMNFF) announced today that Brent Cox, Omar Mangalji, and the Inception Companies, through their affiliate, MMMG-MC, voluntarily dismissed their frivolous lawsuit against MedMen and its related companies, as well as its co-founders Adam Bierman and Andrew Modlin yesterday, in what can only be described as a personal admission that their case was improper. The request for dismissal also follows the Los Angeles Superior Court’s order in January 2019 that stated such claims were not likely to succeed on the merits. After earning millions of dollars as early investors in MMMG LLC, Cox and Mangalji sought to take further advantage of their position as insiders by filing suit against MedMen, Bierman, and Modlin alleging wrongdoing in connection with a common business decision to lock-up certain shares of MedMen held by MMMG.
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
MedMen Enterprises Inc. (“MedMen” or the “Company”) (MMEN.CN) (MMNFF) today announced that Zeeshan Hyder, MedMen chief corporate development officer, will participate in a panel titled “Connecting with U.S. Consumers: Retail and Online Delivery Panel” at the Piper Jaffray 39th Annual Consumer Marketplace Conference on Thursday, June 6th at 11:00 AM Eastern at the Pierre Hotel in New York. The Piper Jaffray 39th Annual Consumer Marketplace Conference brings together key industry executives and investors to provide multiple perspectives, investigate critical trends and identify the leaders in the markets that are driving our economy. Investors interested in arranging a one-to-one meeting at the conference should contact their Piper Jaffray representative.
Recreational pot growth leads the way, but the black market still has a vise grip on the bulk of U.S. cannabis sales.
Upscale dispensary chain MedMen (MMNFF) reported its fiscal third-quarter operating results Wednesday, and they were not pretty. Even with sales growth of close to 20% from the previous year, MedMen lost $63.1 million on an operating basis. This included a more-than-threefold increase in general and administrative expenses tied to construction and new store openings, and a substantial jump in sales and marketing expenses.However, Seaport analyst Brett Hundley believes huge upside remains in a long term window, as he reiterates a Buy rating on MedMen stock with a $7.00 price target. (To watch Hundley's track record, click here)With a market cap of $1.1 billion, MedMen is the leading cannabis retailer in the U.S. and continues to expand (its losses?). The most important market for MedMen is in California, equating to roughly $25 million during the quarter. The company now operates 10 stores in the state, and it continues to expect average store revenue of $20 million/year.Hundley noted, "Without a doubt, most investors around MMNFF want to see the company better manage cash burn and the overall capital structure. If management can better execute against such metrics, we think that company valuation will improve against what we deem is another widely held investor view: the strength of MedMen's brand, footprint and asset base. In addition to simple cost cutting efforts, we think that MedMen is garnering meaningful efficiencies as it widens its footprint inside CA. The company continues to generate cash ($70MM+) from property sales to the Treehouse REIT. Additionally, it has thus far secured $100MM of funding from Gotham Green as a part of its $250MM convertible financing. So long as the company maintains growing responsibility in the middle of the P&L, alongside continued top-line growth in key markets like AZ, NV, FL and MA, we think that capital structure concerns could ease, as well, making for renewed shareholder value creation."The rest of Wall Street echoes Hundley's bullish play, as TipRanks analytics exhibit MedMen stock as a Strong Buy. Out of 4 analysts polled in the last 3 months, all 4 are bullish on the stock stock.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. More recent articles from Smarter Analyst: * Stay Away from Cresco Labs Stock Until the Smoke Clears * Can Aurora Cannabis (ACB) Stock Set Up for Another Breakout? * Village Farms (VFF) Has a Lot Going for It * Hexo Has Difficult Days Ahead, Analyst Says
Cannabis stocks turned lower Thursday, a day ahead of a key hearing by the U.S. Food and Drug Administration, seeking information and data on the substance and its ingredients with the aim of creating a regulatory framework for CBD.
Marijuana stocks were broadly lower Thursday after MedMen revealed it's slashing executive pay amid widening losses.
How MedMen Enterprises Fared in Q3 of Fiscal 2019Third-quarter performanceMedMen Enterprises (MMEN) (MMNFF) reported its third-quarter earnings of fiscal 2019 after the market closed on May 29. For the quarter ended on March 31, the company has
MedMen Enterprises Inc. (OTCQX: MMNFF )'s fiscal third-quarter results saw increased revenue by 22 percent to $36.6 million across operations in California, Nevada, New York, Arizona and Illinois. MedMen ...
Cannabis stocks fell Wednesday, weighed down by weakness in the broader markets and disappointment about some of the latest earnings from the sector.
The cannabis retailer posted strong revenue growth thanks largely to its California stores. But higher spending translated to a worsening bottom line.
MedMen Enterprises Inc. said Wednesday it was cutting executive salaries amid an attempt to manage costs, as the company's losses continue to widen. The cannabis retailer reported fiscal third-quarter comprehensive net losses of $63.1 million, compared with $16.8 million in the year-ago quarter. Medmen logged losses attributable to shareholders of $23.7 million, or 20 cents a share, versus $18.4 million in the year-ago period. MedMen did not provide a year-ago per-share figure. Revenue rose to $36.6 million from $14.3 million in the year-ago period. FactSet does not report enough analyst data about MedMen to form reliable consensus estimates. In the earnings release, the company said that as part of a broad strategy to reduce general and administrative expenses, the company's chief executive and the president have agreed to lower their salaries to $50,000 each. MedMen stock has fallen 15.9% this year, with the S&P 500 index rising 11.8%. MedMen stock closed up 0.5% during regular trading Wednesday.
LOS ANGELES-- -- Increased revenue sequentially by 22% to $36.6 million across the Company’s operations in California, Nevada, New York, Arizona and Illinois Including revenue from pending acquisitions and pre-closing revenue from recently closed acquisitions, pro forma quarterly revenue was approximately $57 million based on third quarter results Decreased corporate SG&A by 9% quarter-over-quarter ...
MedMen Enterprises Inc. (MMEN.CN) (MMNFF) (FSE:A2JM6N) (“MedMen” or the “Company”) is pleased to announce that, further to its press release dated April 23, 2019, MedMen has been advanced an additional US$80,000,000 in gross proceeds pursuant to the US$250,000,000 secured convertible credit facility (the “Facility”) with Gotham Green Partners, an investor in the global cannabis industry. MedMen has issued to the lenders additional convertible senior secured notes (“Notes”), co-issued by the Company and MM CAN USA, Inc., a subsidiary of the Company (“MM CAN”), with a conversion price per Subordinate Voting Share of the Company equal to US$3.29 per share.
Women in the cannabis industry use various tactics to counter the stigma of working in the nascent field.
Why Planet 13 Stock Fell ~6.8% on May 7(Continued from Prior Part)Valuation multipleThe increase in Planet 13 Holdings (PLTH) (PLNHF) stock price since the beginning of 2019 has led to a rise in its valuation multiple. As of May 7, the company was